Lupus study suggests blood-thinner drugs may helpABS CBN NewsBritish drugmaker GlaxoSmithKline and US biotech firm Human Genome Sciences Inc are seeking approval for their keenly awaited lupus drug, Benlysta. …

Related PostsJuly 2, 2010 — MARKET COMMENT: European Shares Flat, Lose 4.5% On Week – Wall Street JournalMarch 11, 2010 — BioInvent and Human Genome Sciences [...]

Avexa hires adviser to undertake reviewNinemsnAvexa Ltd is hiring a corporate advisory firm to undertake a review of the biotech firm. Avexa has hired the bioadvisory group pty ltd to review its …
and more »

Related PostsSeptember 3, 2010 — Lupus study suggests blood-thinner drugs may help – ABS CBN NewsAugust 30, 2010 — French giant Sanofi-Aventis [...]

France24

French giant Sanofi-Aventis bids 14.5 billion euros for US biotech firm GenzymeFrance24The French pharmaceutical giant Sanofi-Aventis unveiled a 14.5-billion-euro offer to buy the US biotech firm Genzyme, which specialises in treatments for …
and more »

Related PostsAugust 30, 2010 — Stocks Return to Losing Ways (MMM, COGT, INTC, IFNNY, SNY, GENZ, HPQ, DELL … – tickerspy NewswireAugust [...]

Ray of hope in fight against EbolaThe StandardThe research was conducted by the US Army Medical Research Institute of Infectious Diseases in collaboration with a Washington-based biotech firm, …
and more »

Related PostsAugust 22, 2010 — Ebola: Scientists see further step against nightmare virus – France24August 20, 2010 — Nutra Pharma begins Indian registration process for Nyloxin [...]

France24

Ebola: Scientists see further step against nightmare virusFrance24… was conducted by the US Army Medical Research Institute of Infectious Diseases in collaboration with a Washington-based biotech firm, AVI BioPharma. …
and more »

Related PostsAugust 23, 2010 — Ray of hope in fight against Ebola – The StandardSeptember 3, 2010 — Lupus study suggests blood-thinner drugs may help [...]

Nutra Pharma begins Indian registration process for Nyloxin pain drugs; seeks …The Pharma LetterUS biotech firm Nutra Pharma Corp (OTC.BB:NPHC), which is developing treatments for adrenomyeloneuropathy, HIV, multiple sclerosis and pain, said yesterday …
and more »

Technorati Tags: Biotech, Biotech USA

Intersouth-Backed Arsenal Medical Raises $3M, Bringing Year’s Total to $15M – cblCitybizlist (press release)By citybizlist Staff DURHAM — Biotech firm Arsenal Medical has completed a $3 million debt offering from one investor, according to an SEC filing, …
and more »

Related PostsAugust 3, 2010 — Stocks take a step backward – Financial News USA (press release)April 13, [...]

HEARD ON THE STREET: Don’t Count on a New Mergers BoomWall Street JournalA clutch of recent deals, including Sanofi Aventis’s approach to US biotech firm Genzyme and GDF Suez’s offer for International Power, …

Technorati Tags: Biotech, Biotech USA

Stocks take a step backwardFinancial News USA (press release)French drugmaker Sanofi-Aventis (SNY) has reportedly entered into friendly takeover talks with US biotech firm Genzyme (GENZ, Fortune 500). …
and more »

Related PostsAugust 3, 2010 — GLOBAL MARKETS: European Stocks Lower; Dollar Slumps – Wall Street JournalJuly 27, 2010 — Takeover Adds to Concern Over GE Animals – [...]

GLOBAL MARKETS: European Stocks Lower; Dollar SlumpsWall Street Journal… Sanofi-Aventis declined 0.1% to EUR45.38 as it enters friendly takeover talks with US biotech firm Genzyme Corp., according to people familiar with the …

Technorati Tags: Biotech, Biotech USA